Zerbor/iStock via Getty Images
Vertex Pharmaceuticals (NASDAQ:VRTX) announced Friday that an expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed its twice-daily cystic fibrosis medication Kaftrio to a new patient group, paving the way for a potential label expansion.
Issuing
